Gynecologic Pathology
Every woman is at risk for developing a gynecologic cancer. It is estimated that there will be about 78,000 new gynecologic carcinomas diagnosed each year. These cancers can involve the vulva, vagina, cervix, uterus, fallopian tubes and ovaries. Medical research has discovered that some classes of genes, called oncogenes and tumor suppressor genes, promote the growth of cancer. Almost all cervical cancers and some cancers of the vagina and vulva are caused by a virus known as HPV, or Human Papillomavirus.
Many of these tumors have only subtle symptoms and must be diagnosed with a biopsy. The division of Gynecologic Pathology provides accurate and timely diagnoses of diagnostic and therapeutic biopsies and second opinions. Specimens include the vulva, vagina, cervix, uterus, fallopian tubes and ovaries and metastatic nodal disease.
Our division is supported by a highly qualified technical staff and laboratory. We have a state of the art immunohistochemistry and molecular pathology laboratory for the study of Gynecologic cancers.
Our division is privileged to provide you the most advanced laboratory tests to rapidly and accurately diagnose your patients.
Test List
Gynecologic Pathology, General Info. (Nicole A. Massoll, M.D.; Edward J. Wilkinson, M.D.; Peter Drew, M.D.; Jacqueline A. Knapik, M.D.; Anthony Yachnis, M.D.; Demaretta Rush, M.D.)
| Test Order Number: | ||
| Methodology: | Light microscopy, electron microscopy, special stains (conventional and immunohistochemistry). DNA ploidy analyses and immunohistochemistry for assessment of possible molar pregnancy. | |
| Specimen Requirements: | Tissue in appropriate fixative; pre-prepared slides and/or paraffin block. | |
| Speciment Handling: | ||
| In-house turnaround time: | 1 to 5 days | |
| Reference Values: | Interpretive report | |
| CPT Code: |